Clinical Trial Update: Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining recombinant human endostatin (Endostar) injections for recurrent metastatic breast cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Xinjiang Medical University | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN